Article
Advancing research diagnostic criteria for Alzheimer's disease: the IWG-2 criteria.
The Lancet. Neurology - 1 Jun 2014
Dubois Bruno, Feldman Howard H, Jacova Claudia, Hampel Harald, Molinuevo José Luis, Blennow Kaj, DeKosky Steven T, Gauthier Serge, Selkoe Dennis, Bateman Randall, Cappa Stefano, Crutch Sebastian, Engelborghs Sebastiaan, Frisoni Giovanni B, Fox Nick C, Galasko Douglas, Habert Marie-Odile, Jicha Gregory A, Nordberg Agneta, Pasquier Florence, Rabinovici Gil, Robert Philippe, Rowe Christopher, Salloway Stephen, Sarazin Marie, Epelbaum Stéphane, de Souza Leonardo C, Vellas Bruno, Visser Pieter J, Schneider Lon, Stern Yaakov, Scheltens Philip, Cummings Jeffrey L
Abstract excerpt
In the past 8 years, both the International Working Group (IWG) and the US National Institute on Aging-Alzheimer's Association have contributed criteria for the diagnosis of Alzheimer's disease (AD) that better define clinical phenotypes and integrate biomarkers into the diagnostic process, covering the full staging of the disease. This Position Paper considers the strengths and limitations of the IWG research...
Topics
- Alzheimer Disease
- Biomarkers
- Humans
- International Cooperation
- Phenotype
- Practice Guidelines as Topic
- Societies, Medical